RA-BEAM, RA-BUILD, RA-BEACON combined
Efficacy measureContinued bari 4 mgStepped down to bari 2 mg
Wk12(N=147)(N=146)
CDAI LDA ≤10§, n (%)136 (92.5)123 (84.2)*
CDAI remission ≤2.8§, n (%)57 (38.8)54 (37.0)
ΔCDAI0.60 (3.44)2.04 (6.29)*
ΔTJC 680.3 (3.0)1.2 (3.8)*
ΔSJC 660.1 (1.7)0.8 (2.7)*
ΔHAQ-DI0.04 (0.26)0.06 (0.28)
ΔPain0.7 (14.7)2.5 (16.4)
ΔPtGA1.2 (14.3)2.5 (14.5)
ΔPhGA−0.0 (9.6)2.7 (13.6)*
ΔCRP0.68 (7.16)1.68 (7.82)
ΔDAS28-CRP0.14 (0.70)0.36 (0.77)*
ΔDAS28-ESR0.10 (0.73)0.35 (0.89)*
ΔSDAI0.69 (3.55)2.19 (6.33)*
  • Values other than CDAI LDA or remission are mean change from baseline (SD) with missing data imputed using modified last observation carried forward; §Missing data imputed using nonresponder imputation; RA-BEAM = MTX-IR pts; RA-BUILD = csDMARD-IR pts; RA-BEACON = bDMARD-IR pts; Δ = change from baseline; CDAI = Clinical Disease Activity Index; CRP = C-reactive protein; DAS28 = Disease Activity Score modified to include the 28 diarthrodial joint count; ESR = erythrocyte sedimentation rate; HAQ-DI = Health Assessment Questionnaire-Disability Index; PhGA = Physician's Global Assessment of Disease Activity; PtGA = Patient's Global Assessment of Disease Activity; SD = standard deviation; SDAI=Simplified Disease Activity Index; SJC = swollen joint count based on 66 joints; TJC = tender joint count based on 68 joints; *p≤0.05 vs. bari 4 mg.